Connect your AI

Welltower WELL Outpatient Medical — Impact of foreign currency translation

Similar metrics at other companies

VREXMedical — Foreign currency translation adjustments

$1.2M—

AFLMedical and other health — Foreign currency translation

-$452M-136%

AFLMedical and other health — Foreign currency translation and other

-$38M-136%

CLOral, Personal and Home Care — Foreign currency translation

$52M+254%

BAXHealthcare Systems & Technologies — Currency translation and other

$5.5M+257%

HURNHealthcare — Foreign currency translation

$0—

Other financials

Income statement

Revenue$3.4B+38.3%

Gross profit$1.3B+35.0%

Net income$752.3M+192%

EPS (diluted)$0.61+35.6%

Balance sheet

Cash & equivalents$4.7B+34.3%

Total debt$2.1B+59.5%

Total equity$43.8B+29.0%

Total assets$67.2B+26.1%

Cash flow

Operating cash flow$670.0M+11.9%

CapEx$269.8M+12.3%

Free cash flow$400.2M+11.6%

Valuation

Market cap$177.94B+71.9%

Enterprise value$175.29B+74.5%

Profitability

Gross margin39.8%+0.6pp

Net margin12.4%-0.5pp

FCF margin15.9%-1.4pp

Returns & leverage

Return on equity3.7%+0.2pp

Debt / equity0×0.0×

Where this comes from

Reported directly by Welltower in its filing.

Tagged under the XBRL concept us-gaap:GoodwillForeignCurrencyTranslationGainLoss.

The official record: Welltower’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about Welltower's outpatient medical — impact of foreign currency translation.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Welltower's outpatient medical — impact of foreign currency translation?: Welltower (WELL) reported outpatient medical — impact of foreign currency translation of $0 in Q1 2026.
What does outpatient medical — impact of foreign currency translation mean?: Captures the financial impact of fluctuations in foreign exchange rates on the valuation of outpatient medical assets or earnings denominated in non-functional currencies. This reflects the volatility inherent in operating a cross-border healthcare portfolio.